LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Variations of the Relative Parasympathetic Tone Assessed by ANI During Oocyte Retrieval Under Local Anaesthesia with Virtual Reality : A Randomized, Controlled, Monocentric, Open Study.

    Malard, Florent / Moy, Ludovic / Denoual, Vincent / Beloeil, Helene / Leblong, Emilie

    Journal of medical systems

    2024  Volume 48, Issue 1, Page(s) 39

    Abstract: Transvaginal oocyte retrieval is an outpatient procedure performed under local anaesthesia. Hypno-analgesia could be effective in managing comfort during this procedure. This study aimed to assess the effectiveness of a virtual reality headset as an ... ...

    Abstract Transvaginal oocyte retrieval is an outpatient procedure performed under local anaesthesia. Hypno-analgesia could be effective in managing comfort during this procedure. This study aimed to assess the effectiveness of a virtual reality headset as an adjunct to local anaesthesia in managing nociception during oocyte retrieval. This was a prospective, randomized single-centre study including patients undergoing oocyte retrieval under local anaesthesia. Patients were randomly assigned to the intervention group (virtual reality headset + local anaesthesia) or the control group (local anaesthesia). The primary outcome was the efficacy on the ANI
    MeSH term(s) Humans ; Anesthesia, Local ; Oocyte Retrieval/adverse effects ; Oocyte Retrieval/methods ; Prospective Studies ; Pain/etiology ; Virtual Reality
    Language English
    Publishing date 2024-04-05
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 423488-1
    ISSN 1573-689X ; 0148-5598
    ISSN (online) 1573-689X
    ISSN 0148-5598
    DOI 10.1007/s10916-024-02057-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Study of aneuploidy in large-headed, multiple-tailed spermatozoa: case report and review of the literature.

    Perrin, Aurore / Morel, Frédéric / Moy, Ludovic / Colleu, Daniel / Amice, Véronique / De Braekeleer, Marc

    Fertility and sterility

    2008  Volume 90, Issue 4, Page(s) 1201.e13–7

    Abstract: Objective: To determine the meiotic segregation in large-headed, multiple-tailed spermatozoa.: Design: Analysis of sperm nuclei by fluorescence in situ hybridization (FISH).: Setting: University hospital.: Patient(s): A 34-year-old man with 100% ...

    Abstract Objective: To determine the meiotic segregation in large-headed, multiple-tailed spermatozoa.
    Design: Analysis of sperm nuclei by fluorescence in situ hybridization (FISH).
    Setting: University hospital.
    Patient(s): A 34-year-old man with 100% morphologically abnormal spermatozoa.
    Intervention(s): Dual-color FISH for chromosomes 13 and 21 and triple-color FISH for chromosomes X, Y, and 18 were performed.
    Main outcome measure(s): Aneuploidy rates.
    Result(s): More than 99% of the spermatozoa had abnormal content for chromosomes X, Y, 13, 18, and 21. Diploidy, triploidy, and tetraploidy rates were found to be 18.42%, 6.14%, and 33.99% in triple-color FISH and to be 16.09%, 16.28%, and 38.95% in dual-color FISH.
    Conclusion(s): Our results and those from other investigators show that large-headed, multiple-tailed spermatozoa are associated with a high rate of polyploidy and aneuploidy. Intracytoplasmic sperm injection should not be recommended to those patients, not only because of its low success rate but also because of its high genetic risk.
    MeSH term(s) Aneuploidy ; Azoospermia/genetics ; Azoospermia/pathology ; Humans ; Male ; Middle Aged ; Oligospermia/diagnosis ; Oligospermia/genetics ; Oligospermia/pathology ; Sperm Head/pathology ; Sperm Tail/pathology
    Language English
    Publishing date 2008-10
    Publishing country United States
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80133-1
    ISSN 1556-5653 ; 0015-0282
    ISSN (online) 1556-5653
    ISSN 0015-0282
    DOI 10.1016/j.fertnstert.2007.09.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?

    Guivarc’h-Levêque, Anne / Homer, Lionel / Arvis, Philippe / Broux, Pierre Louis / Moy, Ludovic / Priou, Gérard / Vialard, Jean / Colleu, Daniel / Dewailly, Didier

    Fertility and sterility. 2011 Oct., v. 96, no. 4

    2011  

    Abstract: OBJECTIVE: To verify whether a variable number of days beyond the menses of estrogen (E) pretreatment may impact on controlled ovarian hyperstimulation (COH) outcomes and birth rate using a GnRH antagonist protocol. DESIGN: Single center, prospective, ... ...

    Abstract OBJECTIVE: To verify whether a variable number of days beyond the menses of estrogen (E) pretreatment may impact on controlled ovarian hyperstimulation (COH) outcomes and birth rate using a GnRH antagonist protocol. DESIGN: Single center, prospective, nonrandomized study. SETTING: Nonacademic fertility unit. PATIENT(S): A total of 1,080 women, aged 25–38 years, consecutively included (1,603 cycles). INTERVENTION(S): Given 4 mg/d E₂ valerate, started 3 days before the theoretical date of the next menses up to the first day of stimulation (S1). MAIN OUTCOME MEASURE(S): Hormone serum levels, drug exposure, and main IVF outcomes. RESULT(S): The cancellation rate was similar in the six similarly sized groups according to the number of days with E₂ pretreatment beyond the menses (1–8 days). The mean serum E₂ and LH levels at S1 gradually increased along with E₂ exposure, whereas the mean serum P level decreased. The mean serum E₂ level on the day of hCG administration gradually increased along with E₂ exposure. Serum LH level at S1 correlated significantly and positively to the length of E₂ exposure and to E₂ level on the day of hCG administration. No significant difference was observed for the number of oocytes retrieved and the number of embryos obtained. Women exposed the longest to exogenous E₂ tended to have higher pregnancy rates (PR). CONCLUSION(S): Extending E₂ pretreatment beyond the menses had no deleterious effect on the main COH outcomes and proved to be slightly beneficial.
    Keywords animal ovaries ; antagonists ; birth rate ; blood serum ; drugs ; estradiol ; gonadotropin-releasing hormone ; hormone antagonists ; human chorionic gonadotropin ; in vitro fertilization ; luteinizing hormone ; menstruation ; oocytes ; patients ; pregnancy rate ; women
    Language English
    Dates of publication 2011-10
    Size p. 872-876.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 80133-1
    ISSN 1556-5653 ; 0015-0282
    ISSN (online) 1556-5653
    ISSN 0015-0282
    DOI 10.1016/j.fertnstert.2011.07.1138
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?

    Guivarc'h-Levêque, Anne / Homer, Lionel / Arvis, Philippe / Broux, Pierre Louis / Moy, Ludovic / Priou, Gérard / Vialard, Jean / Colleu, Daniel / Dewailly, Didier

    Fertility and sterility

    2011  Volume 96, Issue 4, Page(s) 872–876

    Abstract: Objective: To verify whether a variable number of days beyond the menses of estrogen (E) pretreatment may impact on controlled ovarian hyperstimulation (COH) outcomes and birth rate using a GnRH antagonist protocol.: Design: Single center, ... ...

    Abstract Objective: To verify whether a variable number of days beyond the menses of estrogen (E) pretreatment may impact on controlled ovarian hyperstimulation (COH) outcomes and birth rate using a GnRH antagonist protocol.
    Design: Single center, prospective, nonrandomized study.
    Setting: Nonacademic fertility unit.
    Patient(s): A total of 1,080 women, aged 25-38 years, consecutively included (1,603 cycles).
    Intervention(s): Given 4 mg/d E(2) valerate, started 3 days before the theoretical date of the next menses up to the first day of stimulation (S1).
    Main outcome measure(s): Hormone serum levels, drug exposure, and main IVF outcomes.
    Result(s): The cancellation rate was similar in the six similarly sized groups according to the number of days with E(2) pretreatment beyond the menses (1-8 days). The mean serum E(2) and LH levels at S1 gradually increased along with E(2) exposure, whereas the mean serum P level decreased. The mean serum E(2) level on the day of hCG administration gradually increased along with E(2) exposure. Serum LH level at S1 correlated significantly and positively to the length of E(2) exposure and to E(2) level on the day of hCG administration. No significant difference was observed for the number of oocytes retrieved and the number of embryos obtained. Women exposed the longest to exogenous E(2) tended to have higher pregnancy rates (PR).
    Conclusion(s): Extending E(2) pretreatment beyond the menses had no deleterious effect on the main COH outcomes and proved to be slightly beneficial.
    MeSH term(s) Adult ; Estradiol/administration & dosage ; Estradiol/blood ; Estrogens/administration & dosage ; Estrogens/blood ; Female ; Fertilization in Vitro/methods ; Gonadotropin-Releasing Hormone/antagonists & inhibitors ; Gonadotropin-Releasing Hormone/blood ; Humans ; Oocyte Retrieval/methods ; Ovarian Hyperstimulation Syndrome/blood ; Ovarian Hyperstimulation Syndrome/etiology ; Ovulation Induction/methods ; Pregnancy ; Pregnancy Rate/trends ; Prospective Studies ; Retrospective Studies ; Time Factors
    Chemical Substances Estrogens ; Gonadotropin-Releasing Hormone (33515-09-2) ; Estradiol (4TI98Z838E)
    Language English
    Publishing date 2011-10
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 80133-1
    ISSN 1556-5653 ; 0015-0282
    ISSN (online) 1556-5653
    ISSN 0015-0282
    DOI 10.1016/j.fertnstert.2011.07.1138
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?

    Guivarc’h-Levêque, Anne / Homer, Lionel / Arvis, Philippe / Broux, Pierre Louis / Moy, Ludovic / Priou, Gérard / Vialard, Jean / Colleu, Daniel / Dewailly, Didier

    Fertility and sterility

    Volume v. 96,, Issue no. 4

    Abstract: OBJECTIVE: To verify whether a variable number of days beyond the menses of estrogen (E) pretreatment may impact on controlled ovarian hyperstimulation (COH) outcomes and birth rate using a GnRH antagonist protocol. DESIGN: Single center, prospective, ... ...

    Abstract OBJECTIVE: To verify whether a variable number of days beyond the menses of estrogen (E) pretreatment may impact on controlled ovarian hyperstimulation (COH) outcomes and birth rate using a GnRH antagonist protocol. DESIGN: Single center, prospective, nonrandomized study. SETTING: Nonacademic fertility unit. PATIENT(S): A total of 1,080 women, aged 25–38 years, consecutively included (1,603 cycles). INTERVENTION(S): Given 4 mg/d E₂ valerate, started 3 days before the theoretical date of the next menses up to the first day of stimulation (S1). MAIN OUTCOME MEASURE(S): Hormone serum levels, drug exposure, and main IVF outcomes. RESULT(S): The cancellation rate was similar in the six similarly sized groups according to the number of days with E₂ pretreatment beyond the menses (1–8 days). The mean serum E₂ and LH levels at S1 gradually increased along with E₂ exposure, whereas the mean serum P level decreased. The mean serum E₂ level on the day of hCG administration gradually increased along with E₂ exposure. Serum LH level at S1 correlated significantly and positively to the length of E₂ exposure and to E₂ level on the day of hCG administration. No significant difference was observed for the number of oocytes retrieved and the number of embryos obtained. Women exposed the longest to exogenous E₂ tended to have higher pregnancy rates (PR). CONCLUSION(S): Extending E₂ pretreatment beyond the menses had no deleterious effect on the main COH outcomes and proved to be slightly beneficial.
    Keywords blood serum ; drugs ; luteinizing hormone ; hormone antagonists ; oocytes ; gonadotropin-releasing hormone ; antagonists ; women ; animal ovaries ; birth rate ; patients ; pregnancy rate ; human chorionic gonadotropin ; in vitro fertilization ; menstruation ; estradiol
    Language English
    Document type Article
    ISSN 0015-0282
    Database AGRIS - International Information System for the Agricultural Sciences and Technology

    More links

    Kategorien

To top